Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Bolormaa, E. Lee, Y. H. Choe, Y. J. Choe, S. A.

Varicella Vaccine Effectiveness and Duration of Protection: A Systematic Review and Meta-Analysis

  • All age groups
  • Varicella
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Dobritoiu, R. Pacurar, D. Vlad, R. M. Plesca, D. A.

Vertical Transmission of Hepatitis B and C-Then and Now-A Comprehensive Literature Systematic Review

  • Pregnant women
  • Newborn
  • Hepatitis B
  • Hepatitis C
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Riches, N. Henrion, M. Y. R. MacPherson, P. Hahn, C. Kachala, R. Mitchell, T. Murray, D. Mzumara, W. Nkoka, O. Price, A. J. Riches, J. Seery, A. Thom, N. Loarec, A. Lemoine, M. Ndow, G. Shimakawa, Y. Thompson, P. Morgan, C. Desai, S. Easterbrook, P. Stockdale, A. J.

Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis

  • Africa
  • Pregnant women
  • Newborn
  • Hepatitis B
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Hemrajani, P. Sharma, M. Gupta, S.

Vitiligo and coronavirus disease 2019 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ahmed, A. Cahn, B. Haber, R.

Wells syndrome: emerging triggers and treatments- an updated systematic review

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.

Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis

  • Western Pacific
  • China
  • All age groups
  • Economic aspects
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Nangsue, C. Srisurapanont, K. Sudjaritruk, T.

A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Ewongwo, A. Sahor, A. F. Ngwa, W. Nwachukwu, C.

A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity

  • All age groups
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Felsher, M. Shumet, M. Velicu, C. Chen, Y. T. Nowicka, K. Marzec, M. Skowronek, G. Pieniazek, I.

A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs

  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Lieberman, J. A. Chu, D. K. Ahmed, T. Dribin, T. E. Abrams, E. M. Anagnostou, A. Blumenthal, K. G. Boguniewicz, M. Chase, N. M. Golden, D. B. K. Hartog, N. L. Heimall, J. R. Ho, T. Lawrence, M. G. Khan, D. A. Minniear, T. D. Mustafa, S. S. Oppenheimer, J. J. Phillips, E. J. Ramsey, A. Rider, N. L. Schneider, L. Shaker, M. S. Spergel, J. M. Stone, C. A. Stukus, D. R. Wang, J. Greenhawt, M. J.

A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology

  • All age groups
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...